Article
Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.
Cancer causes & control : CCC - 1 Aug 2015
Kim J, Johnson L, Skrzynia C, Buchanan A, Gracia C, Mersereau J E
Abstract excerpt
PURPOSE: Major clinical characteristics of BRCA1/2-related cancers include association with estrogen and metabolic consequences. We aimed to evaluate serum estradiol (E2) and insulin-like growth factor 1 (IGF-1) levels as a marker of insulin resistance in BRCA1/2 mutation carriers and high-risk, BRCA-negative controls. METHODS: Eligible cancer-free women (age 18-42 with regular menstrual cycles) who had been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
